open access

Vol 12, No 5 (2017)
Case Reports
Published online: 2017-11-22
Get Citation

ST-elevation myocardial infarction in patient on chronic oral anticoagulation

Artur Dębski, Paweł Tyczyński, Michał Ciszewski, Joanna Zalewska, Zbigniew Chmielak, Adam Witkowski
DOI: 10.5603/FC.2017.0089
·
Folia Cardiologica 2017;12(5):476-478.

open access

Vol 12, No 5 (2017)
Case Reports
Published online: 2017-11-22

Abstract

Approximately 6–8% of patients undergoing percutaneous coronary interventions (PCI) have an indication for long-term oral anticoagulation with vitamin K antagonists (VKA) or novel oral anticoagulants due to various conditions. Primary PCI with adjunctive pharmacological therapy for ST-elevation myocardial infarction (STEMI) patients on chronic VKA treatment carry increased risk of bleeding, however, very few studies are available so far. We describe a patient, who presented with STEMI and international normalized ratio of 4.5 and discuss possible treatment options.

Abstract

Approximately 6–8% of patients undergoing percutaneous coronary interventions (PCI) have an indication for long-term oral anticoagulation with vitamin K antagonists (VKA) or novel oral anticoagulants due to various conditions. Primary PCI with adjunctive pharmacological therapy for ST-elevation myocardial infarction (STEMI) patients on chronic VKA treatment carry increased risk of bleeding, however, very few studies are available so far. We describe a patient, who presented with STEMI and international normalized ratio of 4.5 and discuss possible treatment options.
Get Citation

Keywords

STEMI, oral anticoagulation

About this article
Title

ST-elevation myocardial infarction in patient on chronic oral anticoagulation

Journal

Folia Cardiologica

Issue

Vol 12, No 5 (2017)

Pages

476-478

Published online

2017-11-22

DOI

10.5603/FC.2017.0089

Bibliographic record

Folia Cardiologica 2017;12(5):476-478.

Keywords

STEMI
oral anticoagulation

Authors

Artur Dębski
Paweł Tyczyński
Michał Ciszewski
Joanna Zalewska
Zbigniew Chmielak
Adam Witkowski

References (4)
  1. Roffi M, Patrono C, Collet JP, et al. Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016; 37(3): 267–315.
  2. Karrowni W, Wang TY, Chen AY, et al. Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients. Heart. 2015; 101(4): 264–270.
  3. Karrowni W, Vyas A, Giacomino B, et al. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2013; 6(8): 814–823.
  4. Mahmud E, Patel M. Radial access for ST-segment elevation myocardial infarction interventions: does it really lower mortality? JACC Cardiovasc Interv. 2013; 6(8): 824–826.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl